Volume | 0 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | Mínimo Máximo |
||||||
Minimo del Dia |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Neoleukin Therapeutics Inc | NLTX | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
3.49 | 3.49 |
Operaciones | Volume Operado de la Acción | Volumen promedio | Rango 52 semanas |
---|---|---|---|
0 | 0 | - | 3.05 - 4.70 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
- | 0 | US$ 3.49 | USD |
Información Financiera Neoleukin Therapeutics Inc NLTX
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
40.7M | 11.66M | - | 0 | -36.32M | -3.11 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Neoleukin Therapeutics Inc NLTX
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
10/5/2024 | 15:14 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
10/5/2024 | 06:31 | Edgar (US Regulatory) | Form 8-K - Current report |
07/5/2024 | 05:20 | Edgar (US Regulatory) | Form 8-K - Current report |
26/4/2024 | 13:34 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
26/4/2024 | 13:33 | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders |
26/4/2024 | 13:33 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
22/4/2024 | 15:44 | Edgar (US Regulatory) | Form 8-K - Current report |
02/4/2024 | 14:43 | Edgar (US Regulatory) | Form 8-K - Current report |
18/3/2024 | 15:10 | Edgar (US Regulatory) | Form 8-K - Current report |
18/3/2024 | 15:04 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
14/3/2024 | 19:54 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
14/3/2024 | 19:53 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
Histórico de Datos NLTX
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 3.32 | 3.69 | 3.18 | 3.45 | 33,039 | 0.17 | 5.12% |
1 Year | 4.40 | 4.70 | 3.05 | 3.62 | 150,477 | -0.91 | -20.68% |
3 Years | 55.15 | 56.70 | 1.875 | 11.78 | 238,307 | -51.66 | -93.67% |
5 Years | 19.90 | 90.65 | 1.875 | 33.53 | 271,777 | -16.41 | -82.46% |